BioDiamond
Literature
				1. Anderson HV, Roubin GS, Leimgruber PP, Douglas JS JR, King SB III, Grüntzinger AR. Primary angiographic success rates of percutaneous transluminal coronary angioplasty. Am. J. Cardiol. 1985; 56: 712-717
				
				2. Myler RK, Topol EJ, Shaw RE, Stertzer SH, Clark DA, Fishman J, et al.. Multiple vessel coronary angioplasty: classification, results and patterns of restenosis in 494 consecutive patients. Cath. Cardiovasc. Diag. 1987; 13: 1-15
				
				3. Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS JR, King SB III, Grüntzig AR.
				
				4. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 1985; 72: 1044-1052
				
				4. Simpfendorfer C, Belardi J, Bellamy G, Galain K, Franco I, Hollman J. Frequencies, management and follow-up of patients with acute coronary occulasion after percutaneous transluminal angioplasty. 1987; 59: 267-269
				
				5. De Freyter PJ, van den Brand M, Laarman GJ, van Domburg RT, Serruys PW, Suryapranata H. Acute coronary artery occulation during and after percutaneous transluminal coronary angioplasty: frequency, prediction, clinical course, managment and follow-up. Circulation 1991; 83: 927-936
				
				6. Serruys PW, Luijten HE, Beatt KJ, Feyer PJ DE, Brand M van den, Reiber JHC Incidence of restenose after successful coronary angioplasty: a time-related phenomenon. Circulation 1988; 77: 361-371
				
				7. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Uendo K, Yokoi H, et. al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 299 patients. J. Am. Coll. Cardiol. 1988; 12: 616-623
				
				8. Detre K, Holubokov R, Kelsey S, Coweley M, Kent K, Williams D, et. al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. N. Engl. J. Med. 1988; 318: 265-270
				
				9. Blackshear JL, O'Callagham WG, Califf RM. Medical approaches to prevention of restenosis after coronary angioplasty. J. Am. Coll. Cardiol. 1987; 9: 834-848
				
				10. Pompa JJ, Califf RM, Topol EJ. Clinical trials of restenosis after coronary angioplasty. Circulation 1991; 84: 1426-1436
				
				11. Hermans WRM, Rensing BJ, Strauss BH, Serruys PW. Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a Ĉmagic bullet". 1991; 122: 171-187
				
				12. Carrel A. Results of the permanent intubation of the thoracic aorta. Surg. Gynecol. Obstet 1912; 15: 245-248
				
				13. Dotter CT. Transluminally-placed coilspring endarterial tube grafts: long-term patency in the canine popliteal artery. Invest. Radiol. 1969; 4: 329-332
				
				14. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stent to prevent occulation and restenosis after transluminal angioplasty. N. Engl. J. Med. 1987; 316: 701-706
				
				15. Serruyes PW, de Jaegere P, Kiemeneij F, et. al. on behalf of the Benestent Study Group: A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495
				
				16. Fischman DL, Leon MB, Baim DS, et al.. A randomised comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501
				
				17. Serruys PW, Strauss BH, Beatt KJ, Bertrand ME, Peul J, Rickards AF, et. al. Angiographic follow-up after placement of a selfe-expanding coronary-artery stent. N. Engl. J. Med. 1991; 324: 13-17
				
				18. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JD, et. al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multi-center study. Circulation 1991; 83: 148-161
				
				19. De Feyter PJ, De Scheerder I, Van Den Brand M, Laarman G, Suryapranata H, Serruys PW. Emergency stenting for refractory acute coronary artery occulation during coronary angioplasty. Am. J. Cardiol. 1990; 66: 1147-1150
				
				20. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean LS, Baxley WA, et. al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85: 916-927
				
				21. Buck JJ, De Scheerder I, Beatt K, Van Den Brand M, Suryapranata H, De Feyter PJ, et. al. The importance of adequate anticoagulation to prevent early thrombosis after stenting of stenosed venous bypass grafts. Am Heart J. 1991; 121: 1389-1396
				
				22. Strauss BH, Serruys PW, Bertrand M, Peul J, Meier B, Goy J-J, et. al. Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass grafts (European experience-March 1986 to March 1990). Am. J. Cardiol. 1992; 69: 475-481
				
				23. Carrozza JP, Kunitz RE, Levine MJ, Pomerantz RM, Fishman RF, Mansour M,Gibson CM, Senerchia CC, Diver DJ, Safian RD, Baim DS. Angiographic and clinical autcome in intracoronary stenting: immediate and long-term results from a large single-center experience. J. Am Coll. Cardiol. 1992; 20: 328-337
				
				24.Serruys PW. Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards AF, Meier B, Goy J-J, Vogt P, Kappenberger L, Sigwart U. Angiographic follow up of a self- expanding coronary-artery stent. N. Engl. J. Med. 1991; 324: 13-17
				
				25. Georg BS, Voorhees WD, Roubin GS, Fearnot NE, Pinkerton CA, Raizer AE, King SB III, Holmes DR, Topol EJ, Kereiakes DJ, Hartzler GO. Mulicenter investigation of coronary stenting to treat acute or threatenal closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J. Am. Coll. Cardiol. 1993; 22: 135-143
				
				26. Nath FC, Muller DWM, Ellis SG, Rosenschein U, Chapekis A, Quain L, Zimmerman C, Topol EJ. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J. Am. Coll. Cardiol. 1993; 21: 622-627
				
				27. Sutton JM, Ellis SG, Roubin GS, Pinkerton CA, King SB III, Raizner AE, Holmes DR, Kereiakes DJ, Topol EJ. Major clinical events after coronary stenting: the multicenter registry of acute and elective Gianturco-Roubin stent Placement. Circulation 1994; 89: 1126-1137
				
				28. Levine MJ, Leonard BM, Burke JA, Nash ID, Safian RD, Diver DJ, Baim DS. Clinical and angiographic results of balloon-expandable intracoronary stents in right coronary arteries. J. Am. Coll. Cardiol. 1990; 16: 332-339
				
				29. Karas SP, Gravanis MB, Santioian EC, Robinson KA, Andernerg Ka, King SB III. Coronary intimal proliferation after balloon injury and stenting and stenting in swine: an animal model of restenosis. J. Am. Coll. Cardiol. 1992; 20: 467-474
				
				30. Hanke H, Hassenstein S, Kamenz J, Oberhoff M, Baumbach A, Betz E, KarschKR. Prolonged proliferation response of smooth muscle cells after experimental Intravascular stenting: a stent wire related phenomenon. Circulation 1992; 86(suppl I): 1-186
				
				31. Rogers C, Karnovsky MJ, Edelman ER. Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation 1993; 88: 1215-1221
				
				32. Ellis SG, Savage M, Fishman D, Baim DS, Leon M, Goldberg S, Hirsfeld JW, Cleman MW, Teirstein PS, Walker C, Bailey S, Buchbinder M, Topol EJ, Schatz RA. Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Circulation 1992; 86: 1836-1844
				
				33. Gordon PC, Gibson CM, Cohen DJ, Carozza JP, Kuntz RE, Baim DS. Mechanisms of restenosis and redilation within coronary stents: qualitative angiographic assessment. J. Am. Coll. Cardiol. 1993; 21: 1166-1174
				
				34. Clowes AW, Karnowsky MJ. Supression by heparin of smooth muscle cells proliferation in injured arteries. Nature (Lond). 1977; 265: 625-626
				
				35. Henry PD, Bentley KI. Suppression of atherogenesis in cholesterol-fed rabbits treated with nifedipine. J. Clin. Invest. 1981; 68: 1366-1369
				
				36. Thornton MA, Gruentzig AR, Hollman J, King SB III, Douglas JS Jr. Coumadin and aspirin in the prevention of recurrence after transluminal coronary angioplasty: a randomised study. Circulation 1984; 69: 721-727
				
				37. Corcos T., David PR., Val PG., Renkin J., Dangiosse V, Rapold HG. Bourassa MG. Failure of dltiazem to prevent restenosis after percutaneous Transluminal coronary angioplasty. Am. Heart J. 1985; 109: 926-931
				
				38. Whitworth HB, Roubin GS, Hollman J, Meier B, leimgruber PP, Douglas JS JR, King SB III, Gruentzig AR. Effect of nifedipine in recurrent stenosis after percutaneous coronary angioplasty. J. Am. Coll. Cardiol. 1986; 8: 1271-1276
				
				39. Jonasson L, Hol J, Hansson GK. Cyclosporin A inhibits smooth muscle cell proliferation in the Vascular response to injury. Proc. Natl. Acad. Sci. USA. 1988; 85: 2303-2306
				
				40. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan R, David PR. Aspirin and dipyridamole in the prevention of restenosis after percutanous transluminal coronary angioplasty. N. Engl. J. Med. 1988; 318:1714-1719
				
				41. Merhi Y, Roy R, Guidoin R, Herbert J, Mourand W, Benslimane S. Cellular reaction to polyester arterial prostheses impregnated with cross-linked albumin: in vivo studies in mice. Biomaterials 1989; 10: 56-58
				
				42. Fischell TA. Polymeric coatings for stents. Circulation 1996; 94: 1494-1495
				
				43. Hehrlein C, Zimmerman M, Grunze M. et. al. Characteristics of metallicly modified stents and their influence on neointima formation in rabbits. Eur. Heart J 1993; 14: 321
				
				44. van der Giessen WJ, Serruyus PW, Visser WJ, et al. Endothelialisation of intravascular stents. J. intervent Cardiol 1988; 1: 109-120
				
				45. Ozaki Y, Violaris G, Serruys PW. New stent technologies. Prog. Cardiov. Dis. 1996; 2: 129-140
				
				46. Hoffman A.S. Modification of Material Surfaces to affect how they interact with blood. An. N.Y. Acad. Sci.
				
				47. Larsson, R, Olsson P, Lindahl U. Inhibition of Thrombin on surfaces coated with immobilized heparin and heparin.like polysaccharides: a crucial non-thrombogenic principle. Thrombosis research 1980; 19: 43-54
				
				48. Williams D.F. Review: Tissue-biomaterial interactions. J. Mater. Sci. 1987; 22: 3421-3445
				
				49. Cook SD, Renz EA, Barrack RL et al. Clinical and netallogical analysis of retrieved internal fixation devices. Clin Orthop 1985; 194: 236-247
				
				50. Brow Sa, Simpson JP. revice and fretting corrosion of stainless steel plates and screws. J Biomed Mater Res 1981; 15: 867-265
				
				51. Colangelo VJ, Greene ND, Corrosion and Fracture of Type 316 SMO orthopedic implants. J Biomt Mater Res 1969; 3: 247-265
				
				52. Emneus H. Some aspects of ostheosynthetic materials as a foreign body. Acta Orthop Scand 1967; 38: 368-418
				
				53.. Emneus H, Stenman U, Baeklund J. An X-ray spectrographic investigation of the soft tissue around titanium and cobalt alloy implants. Acta Orthop Scan 1960; 30: 226-236
				
				54. Emneus H, Stenman U. Metal implants in the human body. Acta Orthop Scand 1965, 36: 115-126
				
				55. Emneus H. Experimental investigations of corrosion of stainless steels used in bone surgery. Acta
Orthop Scand 1961; 44B (suppl): 1-62
				
				56. Tracana R.B., Sousa J.P., Carvalho G.S. Mouse inflammatory response to stainless steel corrosion products. J. Mater. Sci. 1994; 5: 596-600
				
				57. Klein C.L., Nieder P., Wagner M.., Köhler H., Bittinger F., Kirkpatrick C.J., Lewis J.C. The role of metal corrosion in inflammatory processes: induction of adhesion molecules by heavy metal ions. J. Mater. Sci. 1994; 5: 798-807
				
				58. Hunt J.A. Remes A. Williams D.F. Stimulation of neurophil movement be metal ions. J. Biomed. Mater. Sci. 1992; 26: 816-828
				
				59. Tanguay JF, Zindar JP, Philipps HR III. Stack RS. Current status of iodegradable stents. Cardiol Clin 1994; 12: 699-713
				
				60. Herrmann K., Groth TH., Seifert B., Romaniuk K. Heparin-modified polylactide as biodegradable hemocompatible biomaterial. J. Mater. Sci. 1994; 5: 728-731
				
				61. Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, Sato Y, Yokoi H, Hamasaki N, Nosaka H, Nobuyoshi M. Three year follow-up after implantation of metallic coronary- artery stents. N. Engl. J. Med. 1996; 334: 489-495
				
				62. van der Giessen W.J., van Beusekom H.M.M., van Houten C.D., van Woerkens L.J., Verdouw P.D., Serruys P.W. Coronary stenting with polymer-coated and uncoated self-expanding endoprostheses in pigs. Cor. Art. Dis. 1992; 3: 631-640
				
				63. Grant D.M., McColl I.R., Golozar M.A., Wood J.V.. Plasma assisted CVD for biomedical applications. Diamonds and Related Materials 1992; I: 727-730
				
				64. Dion I., Baquey C., Monties J.R.. Diamond: the biomaterial of the 21st century. Inter. J. Art. Org. 1993; 16: 623-627
				
				65. Dion I., Bordenave L., Lefebre F., et al. Physicochemistry and Cytotoxicity of ceramics Part II: Cytotoxicity of ceramics. J of Mater. Sci.: Materials in Medicine 1994; 5: 18-24
				
				66. Dion I., Roques X., Baquey CH., Baudet E., Basse Cathalinat B., More E.. Hemocompatibility of diamond-like carbon coating. Bio-med. Mater. Eng. 1993; 3: 51-55
				
				67. Lu. L., Jones M.W.. Diamond-like carbon as biological compatible material for cell culture and medical application. Bio-Med. Mater. Eng. 1993; 3: 223-228
				
				68. Parker T.L., Parker K.L., McColl I.R., Grant D.M. Wood J.V. The biocompatibility of low temperature diamond-like carbon films: a transmission electron microscopy, scanning electron microscopy and cytotoxicity study. Diamond and related Materials1994; 3: 1120-1123
				
				69. Tang L., Tsai C., Gerberich W.W., Kruckeberg L., Kania D.R. Biocompatibility of chemical-vapour- deposited diamond. Biomaterials 1995; 16: 483-488
				
				70. Thomson L.A., Law F.C., Rushton N. Biocompatibility of diamond-like carbon coating. Biomaterials 1991; 12: 37-40
				
				71. Herbst F. Ionendiffusionsbarriere
				
				72. Yasuda, Hirotsugu, Koge. A method of making a biocompatible prosthesis. PCT application, patent No.: WO89/11919
				
				73. Kobashi K, Nishimura K, Kawate Yoshio, Horiuchi T. Synthesis of diamonds by use of microwave plasma chemical-vapour deposition: Morphology and growth of diamond films. Am. Phys. Soci. Rev. B; 1988: 38-6: 4067-4084
				
				74. Saito Y, Matsuda S, Nogita S. Synthesis of diamond by decomposition of methane in microwave plasma. J. Mater. Sci. Let. 1986; 5: 565-568
				
				75. Robertson J. Mechanical properties and structure of diamond-like carbon. 1992; I: 397-406
				
				76. Geis M.W. Tamor M.A. Diamond and diamond like carbon. Enzcyclo. of Appl. ys. 1993; 5: 1- 24
				
				77. Eversole V, U.S. Patents No. 3,030,187 and No. 3,030,188 1962
				
				78. Deryagin D.V., Fedoseev D.V., Lukyanovich V.M., Spitzin B.V., Ryabov V.A., Lavrentyev A.V. J. Cryst. Growth 1968; 2: 380
				
				79. Deryagin D.V., Builov L.L., Zubkov V.M., Kochergina A.A., Fedoseev D.V. Kristallografiya 1969; 14: 535
				
				80. Deryagin D.V., Lyuttsau D.V., Fedoseev D.V., Ryabov V.A. Dokl. Akad. Nauk SSR 1970; 190: 86
				
				81. Kurihara K, Sasaki K, Kawarada M, Koshio N. High rate synthesis of diamond by dc plasma jet chemical vapor deposition. Appl. Phys. Lett. 1988; 52: 437-8
				
				82. Kobashi K, Nakane A. Glass JT, Buckley-Golder IM. Micro-fabrication of diamond films: selective deposition and etching
				
				83. Soear KE, Frenklach M, Badzian A, Meisser R. Vapor deposition of cristalline diamond; 1085-102
				
				84. Chang CP, Flamme DL, Ibbotson DE, Mucha JA. Diamond crystal growth by plasma chemical vapor deposition. J. Appl. Phys. 1988; 63: 1744-1748
				
				85. Saito Y, Sato K, Gomi K, Miyadera H. Diamond synthesis from COH2 mixed gas plasma. J. of Mater. Sci. 1990; 25: 1246-1250
				
				86. Mitsuda Y, Kojima Y, Yoshida T, Akashi K, the growth of diamonds in microwave plasma under low preassure. J. of Mater. Sci. 1987; 22: 1557-1562
				
				87. Kobashi K, Nishimura K, Kawate Y, Horiuchi T. Synthesis of diamonds by use of microwave plasma chemical vapor deposition : morphology and the growth of diamond films. Physical Review B 1988; 38: 4067-4084
				
				88. Saito Y, Sato K, Tanaka H, Fuijita K, Matsuda S. Diamond synthesis from methan-hydrogen-water mixed gas using a microwave plasma. J. of Mater. Sci. 1988; 23: 842-846
				
				89. Saito Y, Matsuda S, Nogita S. Synthesis of diamond by decomposition of methan in microwave plasma. J. of Mater. Sci. Letters 1986; 5: 565-568
				
				90. Gotman I. Characteristics of metals used in Implants. J. Endourol. 1997 Dec; 11(6): 383-389
				
				91. Mers DC. Metals in medicine and surgery. Int. Met. Rev. 1977; 22: 119-155
				
				92. Williams DF. Titanium and titanium alloys. Williams DF (ed). Biocompatibility of clinical implant materials. Vol II. Boca raton, FL: CRC Press, 1981: 9-44
				
				93. Sutow EJ, Pollack SR. The biocompatibility of cetrain stainless steels. Ibid.: 45-98
				
				94. Williams DF. The properties and clinical uses of cobalt-based alloys. Ibid.: 99-127
				
				95. Woodman J.L. Black J. Nunamaker D.M.. Release of cobalt and nickle from a new total finger joint prosthesis made of vitallium. J. Biomed. Mater. Res. 1983; 17: 655-668
				
				96. Reuling N. Wisser W. Jung A. Denschlag H.O. Release and detection of dental corrosion products in vivo: Development of an experimental model in rabbits. J. Biomed. Mater. Res. 1990; 24: 979-991
				
				97. Brown S.A. Merritt K. Electrochmical corrosion in saline and serum. J. Biomed. Mater. Res.1980; 14: 173-175
				
				98. Brown S.A., Simpson J.P.. Crevice and fretting corrosion of stainless-steel plates and screws. J. Biomed. Mater. Res. 1981; 15: 867-878
				
				99. Woodman J.L., Black J., Jiminez S.A.. Isolation of serum protein organometallic corrosion products from 316LSS and HS-21 in vitro and in vivo. J. Biomed. Mater. Res.; 19: 99-114
				
				100. Berger-Gorbet M., Broxup B., Rivard C., Yahia L' H.. Biocompatibility testing of NiTi screws using immunohistochemistry on sections containing metallic implants. J. Biomed. Mater. Res. 1996; 32: 243-248
			
